We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Versartis Initiates Phase 1 Clinical Trial of VRS-317 Monthly Human Growth Hormone Therapy

Product News   Mar 30, 2011

 
Versartis Initiates Phase 1 Clinical Trial of VRS-317 Monthly Human Growth Hormone Therapy
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Chiral Technologies, Inc. Acquires Arbor Biosciences – Increasing Their Portfolio for the Biopharma Industry

Product News

Arbor have recently expanded into synthetic biology with a cell-free expression system using linear DNA as template for rapid protein expression.

READ MORE

BellBrook Labs Launches Transcreener cGAS Activity Assay to Accelerate Drug Discovery

Product News

The assay will be used to discover and develop new treatments for autoimmune diseases and cancer by strategically targeting the cGAS-STING pathway.

READ MORE

Bio-Rad Publishes New Findings on Generation and Characterization of Drug-Target Complex-Specific Antibodies

Product News

Published in the peer-reviewed journal mAbs, the paper introduces complex-specific antibodies for pharmacokinetic analysis of biotherapeutics.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE